3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Hepatocellular
8
Small Cell Lung Carcinoma
5
Carcinoma, Transitional Cell
5
Neoplasms
4
Melanoma
3
Lung Neoplasms
3
Breast Neoplasms
2
Unresectable Hepatocellular Carcinoma
1
Triple Negative Breast Neoplasms
1
Sarcopenia
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Ultrasonography
3
Walking Speed
2
Tomography, X-Ray Computed
2
Hand Strength
2
Gastrectomy
2
Esophagectomy
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Testosterone
1
Standard of Care
1
Preoperative Exercise
1
Nivolumab
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Hepatectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Exercise Test
1
Colectomy
1
Chemotherapy, Adjuvant
1
Carboplatin
1
CP protocol
1
Adiposity
1
4-azidosalicylic acid-phosphatidylserine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcopenia
×
atezolizumab
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled